Euclidean Capital LLC Long-Term Concentrated

CIK: 0001825034 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $113,975 (100.0% shares, 0.0% debt)

Holdings (10)

INDA ISHARES TR 41.4%

Value ($000) $47,238 Shares 1,200,144 Est. Cost $40.50 Unrealized —

— 23ANDME HOLDING CO 20.5%

Value ($000) $23,354 Shares 10,243,122 Est. Cost $3.83 Unrealized —

PMVP PMV PHARMACEUTICALS INC 9.8%

Value ($000) $11,147 Shares 2,336,909 Est. Cost $39.23 Unrealized -82.1%

— RAPT THERAPEUTICS INC 7.0%

Value ($000) $7,944 Shares 432,900 Est. Cost $19.75 Unrealized —

FHTX FOGHORN THERAPEUTICS INC 6.9%

Value ($000) $7,820 Shares 1,261,261 Est. Cost $19.16 Unrealized -65.8%

ALEC ALECTOR INC 5.3%

Value ($000) $6,072 Shares 980,894 Est. Cost $12.43 Unrealized -34.5%

ORIC ORIC PHARMACEUTICALS INC 3.7%

Value ($000) $4,261 Shares 747,550 Est. Cost $28.69 Unrealized -81.8%

— NGM BIOPHARMACEUTICALS INC 2.7%

Value ($000) $3,046 Shares 746,674 Est. Cost $30.30 Unrealized —

TNYA TENAYA THERAPEUTICS INC 2.3%

Value ($000) $2,610 Shares 915,705 Est. Cost $21.49 Unrealized -86.9%

— SURROZEN INC 0.4%

Value ($000) $483 Shares 802,963 Est. Cost $7.08 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INDA	ISHARES TR	1,200,144	$47,238	41.4%	$40.50	—	MSCI INDIA ETF	46429B598
—	23ANDME HOLDING CO	10,243,122	$23,354	20.5%	$3.83	—	CLASS A COM	90138Q108
PMVP	PMV PHARMACEUTICALS INC	2,336,909	$11,147	9.8%	$39.23	-82.1%	COM	69353Y103
—	RAPT THERAPEUTICS INC	432,900	$7,944	7.0%	$19.75	—	COM	75382E109
FHTX	FOGHORN THERAPEUTICS INC	1,261,261	$7,820	6.9%	$19.16	-65.8%	COM	344174107
ALEC	ALECTOR INC	980,894	$6,072	5.3%	$12.43	-34.5%	COM	014442107
ORIC	ORIC PHARMACEUTICALS INC	747,550	$4,261	3.7%	$28.69	-81.8%	COM	68622P109
—	NGM BIOPHARMACEUTICALS INC	746,674	$3,046	2.7%	$30.30	—	COM	62921N105
TNYA	TENAYA THERAPEUTICS INC	915,705	$2,610	2.3%	$21.49	-86.9%	COM	87990A106
—	SURROZEN INC	802,963	$483	0.4%	$7.08	—	COM	86889P109